Related Experiment Video
Updated: Jul 19, 2026
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Pharmacist-led cardiac risk reduction model.
Tracey H Taveira1, Wen-Chih Wu, Oanh J Martin
1University of Rhode Island, College of Pharmacy, Kingston, RI, USA. ttaveira@uri.edu
Preventive Cardiology
|November 7, 2006
Summary
The Cardiovascular Risk Reduction Clinic (CRRC) effectively lowers cardiovascular risk scores in veterans with diabetes or coronary artery disease. This pharmacist-led program improved key risk factors, reducing overall cardiovascular event risk.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Cardiovascular disease remains a leading cause of mortality.
- Managing multiple modifiable risk factors is crucial for prevention.
- Pharmacist-coordinated care models offer a structured approach to risk reduction.
Purpose of the Study:
- To evaluate the effectiveness of the Cardiovascular Risk Reduction Clinic (CRRC) model.
- To assess changes in cardiovascular risk using the Framingham point score.
- To identify improvements in guideline adherence for major modifiable risk factors.
Main Methods:
- Retrospective analysis of 375 veterans' data from 2001-2002.
- Inclusion of patients with diabetes and/or coronary artery disease referred to CRRC.
- Comparison of Framingham point scores before and after CRRC intervention.
Main Results:
- Overall Framingham point score decreased from 14.5 to 13.6.
- Significant improvements observed in patients not at target goals at baseline.
- Enhanced guideline adherence for LDL cholesterol, systolic blood pressure, HbA1c, and smoking cessation.
Conclusions:
- The CRRC pharmacist-coordinated care model effectively reduces cardiovascular risk.
- The model demonstrates success in managing multiple risk factors in high-risk veteran populations.
- CRRC intervention leads to measurable improvements in cardiovascular health outcomes.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...